Skip to content
LauréoBetaPublic procurement intelligence
Settings
My account

PRODUITS IMMUNISANTS «VACCIN CONTRE R.R.O.V»

Source: SEAO

SigmaSanté · Method not published · closed November 22, 2018 at 2:00 p.m., Quebec time

Facts

Published
October 25, 2018
Time to award
26 days after closingmedian, all notices: 26 d (over 119,539 notices)
how it's calculated — Time to award

Time to award — where the number comes from

The calculation
Calendar days between closing (November 22, 2018) and the first award date published for this notice (December 18, 2018): 26 days.
What goes in
For this notice, every dated award counts, whatever its status, and the earliest date is kept. The median across all notices only keeps the notices whose earliest dated winning award, neither cancelled nor unsuccessful, falls on or after the closing day — over 119,539 notices.
Distribution
Source
SEAO — Quebec open data · CC-BY 4.0 · data up to date as of October 4, 2026 · link to this detail
Method
0
Time to submit
28 days · computed between publication and closing
how it's calculated — Time to submit

Time to submit — where the number comes from

The calculation
Days between publication (October 25, 2018) and closing (November 22, 2018), rounded to the day: 28 days.
What goes in
The source publishes no duration for this notice: the number comes from its two dates. A gap of less than half a day, or a closing before publication, gives no window.
Source
SEAO — Quebec open data · CC-BY 4.0 · data up to date as of October 4, 2026 · link to this detail
Value
— not declared
Reference
Notice no. 2019-4712-00-01
UNSPSC
51201628Vaccin contre la rougeole, les oreillons et la rubéole
SEAO category
G21 — Fourniture et équipement médicaux et produits pharmaceutiques

SEAO, Données Québec · data as of October 4, 2026

Description

100%

SigmaSanté est un organisme à but non lucratif en matière d’approvisionnement en commun de biens et services agissant à titre de mandataire de la Direction générale adjointe de la protection de la santé publique du Ministère de la Santé et des Services sociaux du Québec (D.G.A.P.S.P.) a lancé l’appel d’offres portant le numéro 2019-4712-00-01 pour l’acquisition de PRODUITS IMMUNISANTS «VACCIN CONTRE R.R.O.V» L’appel d’offres vise l’approvisionnement des vaccins suivants :

Read more — 1,198 charactersShow less
  • •
    Vaccin combiné contre la rougeole, la rubéole et les oreillons (RRO),
  • •
    Vaccin à virus vivant atténue contre la varicelle (Var),
  • •
    Vaccin contre la rougeole, la rubéole, les oreillons et la varicelle ( RRO-Var).

L’entente à intervenir est d’une durée initiale de DEUX (2) ans avec des prix fermes et assortie d’UNE (1) option de renouvellement de DOUZE(12) mois selon les modalités prévues au Contrat Pour être valides et considérées, les Soumissions doivent être adressées à SigmaSanté et reçues au plus tard 22 novembre 2018 à 14 :00 :00 heures, (l’heure de réception d’une Soumission est réputée être celle indiquée par l’horloge qui se trouve au bureau de réception des Soumissions). Les soumissionnaires sont tenus de prendre connaissance des exigences décrites aux documents d’appel d’offres. SigmaSanté ne s’engage pas à accepter ni la plus basse ni aucune des soumissions reçues. Elle se réserve en outre le droit de rejeter toutes les soumissions reçues, si elle le juge à propos, sans pour autant être tenue responsable ou faire l’objet d’une poursuite ou réclamation pour les frais ou pertes subis par les soumissionnaires. RESPONSABLE DU DOSSIER : Bertha Myrthil Courriel : (email on the official notice)

SEAO, Données Québec · data as of October 4, 2026

Precedents — this code at this buyer

Where do these figures come from?
reserved · subscriptionViews used up for this month: this block opens with an account.

Bidders

Bidders
CompanyAmount submittedEligibility
GLAXOSMITHKLINE INC.$2,694,750declaredEligible and compliant
MERCK CANADA INC.$9,754,150declaredEligible and compliant

Bids range from $2,694,750 to $9,754,150 — a 262.0% spread between the lowest and the highest.The table is not sorted by amount: the source publishes no ranking, and we do not manufacture one.

2 bids received · 2 of 2 amounts declared

SEAO, Données Québec · data as of October 4, 2026

The price to beat

—code medianCode 51201628 carries a single public tender with offers. Below ten, Lauréo publishes no median for a code: the figure would exist, and it would be worth nothing.
87.2%gap to the marketover 108,521 noticeshow it's calculated

Gap to the market — where the number comes from — where the number comes from

The calculation
Elsewhere in the market, the lowest sits at 87.2% on median (quartiles 74.8 – 94.4%, over 108,521 public tenders).
What goes in
The market reference applies the same rule to each notice, then takes the median of these percentages over 108,521 notices.
Source
SEAO — Quebec open data · CC-BY 4.0 · data up to date as of October 4, 2026 · link to this detail
how it's calculated — The price to beat

The price to beat — where the number comes from

The calculation
$2,694,750 (the lowest) ÷ $6,224,450 (the median of the 2 bids) = 43.3%
What goes in
The amounts bid on this notice that are above zero and published in the source's unit “1”: two different units do not compare. At least two distinct amounts are needed. The market reference applies the same rule to each notice, then takes the median of these percentages over 108,521 notices.
Breakdown
Lowest
$2,694,750
Median of offers
$6,224,450
Highest
$9,754,150
The lowest bid sits at 43.3% of the median of the amounts received.These are submitted amounts, not the signed contract.
Source
SEAO — Quebec open data · CC-BY 4.0 · data up to date as of October 4, 2026 · link to this detail

SEAO, Données Québec · data as of October 4, 2026

Contracting authority history — most recent awards

Where do these figures come from?
reserved · subscriptionViews used up for this month: this block opens with an account. Free with an account

Award

Winners and awarded amounts
YearWinnerValue
2018GlaxoSmithKline Inc.$447,000declared
2018MERCK CANADA INC.$28,542,450declared

2 distinct winners share this public tender. The source declares no link between them: these are separate awards on one public tender, most often one lot each.

Signed contracts and their end dates
ContractSignedEnd dateContract amount
1760744The signed contract exceeds the awarded amount by $753,642 — +168.6%. A gap is a fact, not a judgement: across 121,996 comparable pairs it exists in 62% of cases, and half of them are below the awarded amount.2018March 30, 2022$1,200,642declared
1760745The signed contract exceeds the awarded amount by $3,158,282 — +11.1%. A gap is a fact, not a judgement: across 121,996 comparable pairs it exists in 62% of cases, and half of them are below the awarded amount.2018March 30, 2022$31,700,732declared

SEAO, Données Québec · data as of October 4, 2026

Documents

the source is silent — No document in the open dataset · SEAO notice

Similar open notices

the source is silent — No Québec notice still open under 51201628, nor in its class (512016) or its family (5120).

Cite this page
Permalink
https://www.laureo.ca/en/avis/ocds-ec9k95-1209661
Citation
Lauréo, “PRODUITS IMMUNISANTS «VACCIN CONTRE R.R.O.V»”, SigmaSanté, notice no. 2019-4712-00-01, data as of October 4, 2026, from SEAO / Données Québec (CC-BY 4.0). https://www.laureo.ca/en/avis/ocds-ec9k95-1209661
Reuse
Figures and text reusable with attribution. SEAO documents are never redistributed: they are linked to their official source.
Report an error